Report error Found 68 with Last Name = 'tartar' and Initial = 'a'
Affinity DataIC50: 3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataIC50: 3.30nMAssay Description:Tested for the inhibition to V2 subtype receptor using [3H]- (VS2) as radioligand at 3 nM and arginine-vasopressin at 2 uM in LLCPKI cellsMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Displacement of ATP from protein kinase A (PKA)More data for this Ligand-Target Pair
Affinity DataIC50: 9.5nMAssay Description:Tested for the inhibition to V2 subtype receptor using [3H]- (VS2) as radioligand at 3 nM and arginine-vasopressin at 2 uM in LLCPKI cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 9.5nMAssay Description:Tested for the TYR(Me)2 arginine-vasopressin as radioligand at 0.3 nM in A7r5 cellsMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Tested for the TYR(Me)2 arginine-vasopressin as radioligand at 0.3 nM in A7r5 cellsMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
Affinity DataEC50: 33nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 40nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 80nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
Affinity DataEC50: 100nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
TargetO94806/P05129/P05771/P17252/P24723/P41743/Q02156/Q04759/Q05513/Q05655/Q15139(Human)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Displacement of ATP from protein kinase C (PKC)More data for this Ligand-Target Pair
Affinity DataKi: 170nMAssay Description:Displacement of ATP from protein kinase A (PKA)More data for this Ligand-Target Pair
Affinity DataEC50: 200nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus type 1)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataEC50: 200nMAssay Description:Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.More data for this Ligand-Target Pair
Affinity DataEC50: 230nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
TargetO94806/P05129/P05771/P17252/P24723/P41743/Q02156/Q04759/Q05513/Q05655/Q15139(Human)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of protein kinase C (PKC)More data for this Ligand-Target Pair
Affinity DataEC50: 430nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 470nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 480nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 570nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 640nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 810nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 850nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 890nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 1.10E+3nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataEC50: 1.20E+3nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 1.30E+3nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 1.50E+3nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+3nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+3nMAssay Description:Effective concentration for human Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataEC50: 2.20E+3nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 2.30E+3nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataEC50: 2.80E+3nMAssay Description:Effective concentration for human Oxytocin receptorMore data for this Ligand-Target Pair
Affinity DataKi: 3.00E+3nMAssay Description:Displacement of ATP from protein kinase A (PKA)More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of cAMP-dependent protein kinase (PKA).More data for this Ligand-Target Pair
TargetO94806/P05129/P05771/P17252/P24723/P41743/Q02156/Q04759/Q05513/Q05655/Q15139(Human)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataKi: 6.00E+3nMAssay Description:Displacement of ATP from protein kinase C (PKC)More data for this Ligand-Target Pair
TargetO94806/P05129/P05771/P17252/P24723/P41743/Q02156/Q04759/Q05513/Q05655/Q15139(Human)
Ura Cnrs 1309
Curated by ChEMBL
Ura Cnrs 1309
Curated by ChEMBL
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of protein kinase C (PKC)More data for this Ligand-Target Pair






























